FDA panel: No cold meds for under-6 kids

The concerns about cough-and-cold meds for kids culminated Friday in an FDA advisory group vote against the products. The expert group concluded that there's not enough evidence that the drugs work--and plenty of evidence that they can be harmful--so they shouldn't be used in children under the age of 6.

The 13-to-9 decision was by no means unanimous, though. Some panelists believe parents depend on the drugs for help when a child is sick. Americans spend more than $300 million a year on these products. The agency probably will work with the industry to come up with a voluntary action plan, because formal proceedings could take years, FDA officials told the Washington Post.

- read the report from the Washington Post

Related Articles:
FDA experts mull ban on child cold meds. Report
Drug makers recall infant cold meds. Report
FDA to review OTC cough medicine safety. Report

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Oklahoma politicians contend J&J should be on the line for future abatement costs even after a $572 million verdict, but J&J sees things differently.

Abbott helmsman Miles White, who oversaw the spinoffs of AbbVie and Hospira, will step down as CEO after 21 years at the top job.